KRT9 Antibody

• Background:

  KRT9 is the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this protein cause epidermolytic palmoplantar keratoderma.

• NCBI Gene ID:

  3857

• Swiss Prot:

  P35527

• Accession Number:

  P35527

• Host:

  Rabbit

• Reactivity:

  Human

• Immunogen:

  This KRT9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 429-456 amino acids from the Central region of human KRT9.

• Clonality:

  Polyclonal

• Conjugation:

  Unconjugated

• Type:

  Primary Antibodies

• Field of Research:

  Signal Transduction

• Purification:

  This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis

• Concentration:

  Batch dependent

• Buffer:

  Supplied in PBS with 0.09% (W/V) sodium azide.

• Modification:

  None

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

• Calculated Molecular Weight:

  62 kDa

• Fragment:

  Rabbit Ig

• Applications Notes:

  For WB starting dilution is: 1:1000

• Symbol:

  KRT9

• NCBI Official Name:

  Keratin, type I cytoskeletal 9

• NCBI Organism:

  Homo sapiens

• Background Reference 01:

  Feng, W., Han, W. EurDermatol 18 (4), 387-390 (2008)

• Background Reference 02:

  Zhao, J.J., Zhang, Z.H. Int. J. Dermatol. 47 (6), 634-637 (2008)

• Background Reference 03:

  Torchard, D., Blanchet-Bardon, C. Nat. Genet. (1), 106-110 (1994)

• Background Reference 04:

  Reis, A., Kuster, W. Hum. Genet. 90 (1-2), 113-116 (1992)

• Other Product Names:

  Keratin, type I cytoskeletal 9, Cytokeratin-9, CK-9, Keratin-9, K9, KRT9

• Tested Applications:

  WB, IHC-P

• Protein ID:

  239938886

• Physical Properties:

  Liquid